118 related articles for article (PubMed ID: 7626391)
1. Hematologic recovery after marrow-ablative chemotherapy and peripheral blood stem cell transplantation in children.
Matsuzaki A; Kai T; Ohga S; Nomura A; Inaba S; Harada M; Ishii E; Ueda K
Pediatr Hematol Oncol; 1995; 12(2):201-4. PubMed ID: 7626391
[No Abstract] [Full Text] [Related]
2. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
Ho AD; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham RE
Leukemia; 1993 Nov; 7(11):1738-46. PubMed ID: 7901454
[TBL] [Abstract][Full Text] [Related]
3. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
4. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
6. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
[TBL] [Abstract][Full Text] [Related]
7. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
8. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
[TBL] [Abstract][Full Text] [Related]
9. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
[TBL] [Abstract][Full Text] [Related]
10. Dose-intensified therapy combined with autologous blood stem cell support in patients with multiple myeloma.
Serke S; Kirsch A; Huhn D
Semin Oncol; 1994 Dec; 21(6 Suppl 16):29-32. PubMed ID: 7528448
[No Abstract] [Full Text] [Related]
11. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
J Clin Oncol; 1995 Oct; 13(10):2547-55. PubMed ID: 7595706
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
Sureda A; Canals C; Badell I; Nomdedeu J; Llácer M; Brunet S; Sierra J; Grañena A; Cubells J; Domingo-Albós A
Prog Clin Biol Res; 1992; 377():315-20. PubMed ID: 1438428
[No Abstract] [Full Text] [Related]
13. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.
Sosman JA; Stiff PJ; Bayer RA; Peliska J; Peace DJ; Loutfi S; Stock W; Oldenburg D; Unverzagt K; Bender J
Bone Marrow Transplant; 1995 Nov; 16(5):655-61. PubMed ID: 8547862
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Hassan HT; Zander AR
J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
[TBL] [Abstract][Full Text] [Related]
15. [Peripheral blood stem cell autografts in pediatric cancer].
Takaue Y
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2307-12. PubMed ID: 1979725
[TBL] [Abstract][Full Text] [Related]
16. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Kritz A; Crown JP; Motzer RJ; Reich LM; Heller G; Moore MP; Hamilton N; Yao TJ; Heelan RT; Schneider JG
Cancer; 1993 Apr; 71(8):2515-21. PubMed ID: 8095854
[TBL] [Abstract][Full Text] [Related]
17. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
19. [Recovery kinetics of hematopoiesis after peripheral blood stem cell autotransplantation].
Takaue Y; Watanabe T; Kawano Y; Abe T; Suzue T; Satoh J; Kamata K; Huq MA; Ninomiya T; Kuroda Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):781-6. PubMed ID: 2565703
[TBL] [Abstract][Full Text] [Related]
20. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.
Yeung AW; Pang YK; Tsang YC; Wong SW
Cancer; 1994 Apr; 73(7):1960-70. PubMed ID: 7511042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
